T1	Participants 31 108	prevention of vascular thromboembolism in advanced pancreatic cancer patients
T2	Participants 249 344	tissue factor and serum-induced cell invasion in patients with advanced pancreatic cancer (APC)
T3	Participants 348 422	cohort of 39 patients with APC, without thrombosis, receiving chemotherapy
T4	Participants 561 630	19 patients received WAD, the remaining 20 acting as a control group.
T5	Participants 1523 1552	APC patients treated with WAD
